What clinical guideline should we use for the management of osteoporosis?;¿Qué guía clínica debemos utilizar para el tratamiento de la osteoporosis?

Medicina Clinica

Volumn 136, Issue 7, 2011, Pages 293-294

  Roig Vilaseca, Daniel ^a   Gómez Vaquero, Carmen ^b  

^a SAP Baix Llobregat Centre   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; OSTEOPOROSIS; PATIENT CARE; PRACTICE GUIDELINE;

EID: 79952816342     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.09.031     Document Type: Article

References (13)

1. Naranjo A, Ojeda-Bruno S, Francisco-Hernández F, Erausquin C, Rúa-Figueroa I, RodrÍguez-Lozano C. Aplicación de las guÍas clÍnicas de prevención secundaria de fractura osteoporótica y delI ́ndice FRAX en una cohorte de pacientes con fractura por fragilidad. Med ClÍn (Barc). 2011;136:290-2.
2. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: An update for the US Preventive Services Task Force. Ann Intern Med. 2010;153:99-111.
3. Nacional Osteoporosis Fundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Fundation; 2010.
4. Internacional Society for Clinical Densitometry. Updated 2005 official positions of the international society for clinical densitomtry. West Hardford, CT: ISCD; 2005.
5. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385-97.
6. van Geel TACM, van den Berg JPW, Dinant G-J, Geusens PP. Individualizing factor risk prediction. Maturitas. 2010;65:143-8.
7. Roig Vilaseca D, Conesa A, Hoces Otero C, Gómez Vaquero C, Nolla JM. Riesgo de fractura de fémur: Comparación de dos modelos de cálculo. Reumatol ClÍn (esp cong). 2010;6:39.
8. Nguyen ND, Frost SA, Center JR, Eisman JA, Nguyen TV. Dvelopment of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int. 2008;19:1431-44.
9. Ensrud KE, Lui L-Y, Taylor BC, Schousboe JT, Donaldson MG, Fink HA, et al., for the Study of Osteoporotic Fractures Research Group. Arch Intern Med. 2009;169:2087-94.
10. Álvarez-Nebreda ML, Jiménez AB, RodrÍguez P, Serra JA. Epidemiology of hip fracture in the elderly in Spain. Bone. 2008;42:278-85.
11. Tosteson ANA, Melton III LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, et al. Cost-effective osteporosis treatment-thresholds: The United Satates perspective. Osteoporos Int. 2008;19:437-47.
12. Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™). Osteoporos Int. 2008;19:429-35.
13. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A, National Osteoporosis Guideline Group. Case findig for the management of osteoporosis with FRAX1-assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19:1395-408.